PENICILLIN V POTASSIUM

PENICILLIN V POTASSIUM was reported 2586 times

PENICILLIN V POTASSIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ORTHODONTIC APPLIANCE USER 2 0.2500
1 VIPOMA 5 0.2174
2 ACTINOMYCOTIC SEPSIS 5 0.2000
3 OESOPHAGEAL MUCOSAL HYPERPLASIA 2 0.2000
4 PULMONARY VASCULITIS 90 0.1673
5 TOTAL LUNG CAPACITY ABNORMAL 62 0.1594
6 CAPILLARITIS 36 0.1304
7 SPIROMETRY ABNORMAL 65 0.1087
8 ORAL MUCOSA ATROPHY 2 0.1053
9 MITE ALLERGY 66 0.1008
10 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 63 0.0859
11 MYCOTIC ALLERGY 66 0.0772
12 DUST ALLERGY 66 0.0673
13 HYPERPARATHYROIDISM TERTIARY 5 0.0667
14 NEURITIS 90 0.0583
15 COAGULATION FACTOR INCREASED 3 0.0492
16 CONJUNCTIVITIS ALLERGIC 69 0.0466
17 MENINGITIS MENINGOCOCCAL 7 0.0412
18 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 7 0.0405
19 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 81 0.0397
20 ORAL FIBROMA 2 0.0377
21 HERPES ZOSTER INFECTION NEUROLOGICAL 5 0.0314
22 RESPIRATORY SYMPTOM 88 0.0309
23 SPLENIC EMBOLISM 3 0.0261
24 HYPOCALVARIA 3 0.0259
25 LIVER IRON CONCENTRATION INCREASED 2 0.0247
26 FORCED EXPIRATORY VOLUME DECREASED 66 0.0233
27 NORMOCHROMIC NORMOCYTIC ANAEMIA 69 0.0229
28 NATURAL KILLER CELL COUNT DECREASED 2 0.0217
29 PLAGIOCEPHALY 10 0.0200
30 VENTRICULAR HYPOPLASIA 5 0.0200
31 DECORTICATE POSTURE 2 0.0179
32 PULMONARY ALVEOLAR HAEMORRHAGE 91 0.0162
33 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0158
34 NEUROLOGICAL SYMPTOM 90 0.0157
35 CONGENITAL APLASIA 4 0.0129
36 OLIGODIPSIA 3 0.0128
37 ATRIOVENTRICULAR SEPTAL DEFECT 6 0.0128
38 CEREBELLAR HYPOPLASIA 2 0.0119
39 TOOTH EROSION 13 0.0106
40 OBSTRUCTIVE AIRWAYS DISORDER 118 0.0106
41 ARTERIOSCLEROSIS CORONARY ARTERY 69 0.0104
42 APPENDICOLITH 4 0.0103
43 ORAL CAVITY FISTULA 5 0.0102
44 HEART FAILURE WITH PRESERVED EJECTION FRACTION 3 0.0102
45 BREAKTHROUGH HAEMOLYSIS 4 0.0100
46 FULL BLOOD COUNT ABNORMAL 106 0.0100
47 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 2 0.0099
48 FOCAL NODULAR HYPERPLASIA 5 0.0096
49 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 2 0.0082
50 GINGIVAL ABSCESS 6 0.0080
51 ICHTHYOSIS 2 0.0079
52 PANCREATIC NEUROENDOCRINE TUMOUR 5 0.0078
53 MYOCARDIAL DEPRESSION 2 0.0078
54 DANDY-WALKER SYNDROME 2 0.0077
55 CELLULITIS STAPHYLOCOCCAL 5 0.0077
56 VASCULITIS 88 0.0075
57 CONGENITAL RENAL DISORDER 2 0.0075
58 HAEMOSIDEROSIS 2 0.0075
59 ARTERIOSCLEROSIS 70 0.0074
60 DENTAL FISTULA 3 0.0072
61 PARATHYROID TUMOUR BENIGN 5 0.0067
62 ANOGENITAL WARTS 6 0.0067
63 ENTEROBACTER BACTERAEMIA 2 0.0066
64 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 112 0.0066
65 HEAD DEFORMITY 2 0.0065
66 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0065
67 PULMONARY FUNCTION TEST ABNORMAL 10 0.0064
68 CHRONIC ALLOGRAFT NEPHROPATHY 5 0.0064
69 HAPTOGLOBIN DECREASED 5 0.0062
70 PANCREATITIS RELAPSING 5 0.0061
71 VOCAL CORD DYSFUNCTION 3 0.0061
72 ACUTE STRESS DISORDER 2 0.0060
73 RENAL TUBULAR INJURY 7 0.0058
74 FIBROUS HISTIOCYTOMA 2 0.0057
75 HYPERPLASIA 5 0.0056
76 COMPLICATIONS OF BONE MARROW TRANSPLANT 2 0.0055
77 NODULE 70 0.0054
78 MONOCLONAL IMMUNOGLOBULIN PRESENT 4 0.0053
79 ACTINOMYCOSIS 5 0.0052
80 MACROCEPHALY 2 0.0052
81 SITTING DISABILITY 3 0.0049
82 PULMONARY FIBROSIS 93 0.0048
83 TRISOMY 21 6 0.0048
84 OBLITERATIVE BRONCHIOLITIS 6 0.0046
85 ACUTE CHEST SYNDROME 4 0.0046
86 BODY MASS INDEX INCREASED 6 0.0044
87 ECZEMA ASTEATOTIC 2 0.0042
88 HEPATIC HAEMATOMA 2 0.0042
89 VACCINATION FAILURE 7 0.0042
90 GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0041
91 RESPIRATORY TRACT OEDEMA 3 0.0040
92 GENE MUTATION 8 0.0040
93 TOTAL LUNG CAPACITY DECREASED 6 0.0038
94 EXCESSIVE GRANULATION TISSUE 3 0.0037
95 IRON OVERLOAD 4 0.0037
96 HYPOTHYROIDISM 118 0.0037
97 CAMPYLOBACTER INFECTION 3 0.0036
98 BONE FRAGMENTATION 2 0.0036
99 LEUKAEMIA RECURRENT 6 0.0035
100 LIFE EXPECTANCY SHORTENED 2 0.0035
101 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
102 AORTIC CALCIFICATION 2 0.0034
103 NORMOCYTIC ANAEMIA 5 0.0034
104 ENGRAFTMENT SYNDROME 2 0.0034
105 SECONDARY ADRENOCORTICAL INSUFFICIENCY 5 0.0033
106 HAEMOPTYSIS 92 0.0033
107 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 7 0.0033
108 KLEBSIELLA TEST POSITIVE 2 0.0031
109 FORCED VITAL CAPACITY DECREASED 2 0.0031
110 INFUSION SITE URTICARIA 2 0.0030
111 NEURODEVELOPMENTAL DISORDER 2 0.0030
112 CEREBRAL CYST 2 0.0029
113 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
114 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
115 BLOOD HIV RNA INCREASED 5 0.0028
116 ATROPHIC VULVOVAGINITIS 2 0.0027
117 HAEMOGLOBINURIA 3 0.0027
118 OSTEOSCLEROSIS 4 0.0025
119 INTERVERTEBRAL DISC SPACE NARROWING 2 0.0025
120 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 2 0.0025
121 OTITIS EXTERNA 3 0.0025
122 CONGENITAL CYSTIC KIDNEY DISEASE 2 0.0024
123 LUNG HYPERINFLATION 2 0.0023
124 INFUSION SITE BRUISING 5 0.0023
125 GRAFT VERSUS HOST DISEASE 16 0.0022
126 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 106 0.0022
127 CONTRAST MEDIA ALLERGY 4 0.0022
128 CUSHINGOID 7 0.0022
129 TENOSYNOVITIS 6 0.0022
130 LOOSE TOOTH 7 0.0022
131 PERIODONTAL DISEASE 3 0.0021
132 LUPUS NEPHRITIS 4 0.0021
133 VITILIGO 5 0.0021
134 HYPOXIA 75 0.0021
135 WHEEZING 122 0.0021
136 HAEMOPHILUS INFECTION 2 0.0020
137 LUNG DISORDER 100 0.0020
138 HYPERPARATHYROIDISM SECONDARY 5 0.0020
139 RUBBER SENSITIVITY 3 0.0020
140 OSTEOLYSIS 4 0.0020
141 VARICELLA ZOSTER VIRUS INFECTION 4 0.0019
142 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
143 INTERVERTEBRAL DISC COMPRESSION 2 0.0019
144 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 2 0.0018
145 PERIODONTITIS 4 0.0018
146 BLOOD PHOSPHORUS INCREASED 5 0.0018
147 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 5 0.0018
148 PRODUCTIVE COUGH 85 0.0018
149 KLEBSIELLA SEPSIS 2 0.0018
150 DEAFNESS BILATERAL 3 0.0018
151 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 125 0.0018
152 INFECTION REACTIVATION 2 0.0017
153 IMMUNE THROMBOCYTOPENIA 8 0.0017
154 SPONDYLOLISTHESIS 3 0.0017
155 LUMBAR RADICULOPATHY 2 0.0017
156 INFUSION SITE DISCHARGE 3 0.0017
157 GROWTH RETARDATION 5 0.0017
158 HEART DISEASE CONGENITAL 6 0.0017
159 BONE MARROW DISORDER 5 0.0017
160 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
161 TOOTH FRACTURE 18 0.0016
162 INJECTION SITE HYPERSENSITIVITY 5 0.0016
163 GINGIVAL RECESSION 3 0.0016
164 HAEMOLYSIS 12 0.0016
165 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
166 VIRAL LOAD INCREASED 6 0.0015
167 ATROPHY 3 0.0015
168 NASAL DISCHARGE DISCOLOURATION 2 0.0014
169 DENTAL CARIES 16 0.0014
170 PERITONEAL HAEMORRHAGE 2 0.0014
171 TOOTH INFECTION 19 0.0014
172 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
173 HYPERPHOSPHATAEMIA 3 0.0014
174 JAW FRACTURE 3 0.0014
175 BONE LESION 5 0.0014
176 EXPOSED BONE IN JAW 3 0.0014
177 MYASTHENIA GRAVIS 11 0.0014
178 AUTOIMMUNE THYROIDITIS 5 0.0013
179 ASTIGMATISM 2 0.0013
180 ASTHMA 149 0.0013
181 JOINT EFFUSION 9 0.0013
182 NEPHROGENIC ANAEMIA 6 0.0013
183 NEOPLASM SKIN 2 0.0013
184 ORAL SURGERY 3 0.0013
185 YELLOW SKIN 6 0.0013
186 FUNGAEMIA 2 0.0013
187 MYOPIA 3 0.0013
188 BILE DUCT STONE 4 0.0013
189 SPINAL OSTEOARTHRITIS 11 0.0013
190 FINGER DEFORMITY 6 0.0012
191 PLASMA CELL MYELOMA RECURRENT 4 0.0012
192 BACTERIAL SEPSIS 4 0.0012
193 HAEMATOLOGICAL INFECTION 3 0.0012
194 PATHOLOGICAL GAMBLING 2 0.0012
195 MITRAL VALVE PROLAPSE 2 0.0012
196 ENDODONTIC PROCEDURE 3 0.0012
197 PURULENT DISCHARGE 5 0.0012
198 PRODUCT USE COMPLAINT 18 0.0011
199 PULMONARY EMBOLISM 101 0.0011
200 ECONOMIC PROBLEM 16 0.0011
201 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
202 TOOTHACHE 19 0.0010
203 HEART VALVE INCOMPETENCE 3 0.0010
204 BLOOD URIC ACID INCREASED 6 0.0010
205 CONVERSION DISORDER 2 0.0010
206 LUMBAR SPINAL STENOSIS 3 0.0010
207 ABDOMINAL WALL HAEMATOMA 2 0.0010
208 NASAL SEPTUM DEVIATION 2 0.0010
209 NECK INJURY 3 0.0010
210 IMMUNOSUPPRESSION 9 0.0010
211 PLATELET COUNT ABNORMAL 6 0.0010
212 PATHOLOGICAL FRACTURE 5 0.0010
213 DIVERTICULUM 7 0.0010
214 EYELID PAIN 2 0.0010
215 THROMBOSIS 79 0.0010
216 HYPERPARATHYROIDISM 2 0.0010
217 INFUSION SITE SWELLING 6 0.0010
218 SERUM FERRITIN INCREASED 5 0.0009
219 VENTRICULAR HYPOKINESIA 3 0.0009
220 COMPRESSION FRACTURE 5 0.0009
221 ATELECTASIS 9 0.0009
222 BLOOD TESTOSTERONE INCREASED 2 0.0009
223 GINGIVITIS 5 0.0009
224 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
225 TENDON DISORDER 6 0.0009
226 GASTRIC BYPASS 2 0.0009
227 INFUSION SITE HAEMORRHAGE 3 0.0009
228 ENDOMETRIAL CANCER 2 0.0009
229 NEAR DEATH EXPERIENCE 3 0.0009
230 CLOSTRIDIUM TEST POSITIVE 2 0.0009
231 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
232 TOOTH ABSCESS 9 0.0009
233 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
234 ANHEDONIA 23 0.0009
235 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
236 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
237 OSTEOPENIA 13 0.0009
238 SKIN ABRASION 4 0.0008
239 HYPERSENSITIVITY 157 0.0008
240 METASTASIS 6 0.0008
241 TASTE DISORDER 17 0.0008
242 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
243 HUMERUS FRACTURE 4 0.0008
244 FAECES SOFT 6 0.0008
245 TOOTH LOSS 17 0.0008
246 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
247 HYPERVOLAEMIA 4 0.0008
248 MUCOUS STOOLS 4 0.0008
249 SCOLIOSIS 5 0.0008
250 DEVICE INFUSION ISSUE 2 0.0008
251 BONE DENSITY ABNORMAL 3 0.0008
252 LUNG INFILTRATION 7 0.0008
253 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
254 ANAPHYLACTIC REACTION 43 0.0008
255 HAEMOGLOBIN ABNORMAL 5 0.0008
256 AORTIC ARTERIOSCLEROSIS 2 0.0008
257 FAILURE TO THRIVE 4 0.0008
258 TOOTH DISORDER 17 0.0008
259 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
260 BLOOD POTASSIUM ABNORMAL 2 0.0007
261 FUNGAL SKIN INFECTION 3 0.0007
262 LEUKAEMIA 7 0.0007
263 EAR CONGESTION 2 0.0007
264 JAW DISORDER 4 0.0007
265 CONGESTIVE CARDIOMYOPATHY 3 0.0007
266 THROMBOTIC MICROANGIOPATHY 7 0.0007
267 LUNG CONSOLIDATION 2 0.0007
268 ANGIOPATHY 4 0.0007
269 BONE DISORDER 13 0.0007
270 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
271 LIP PAIN 2 0.0007
272 MOUTH SWELLING 4 0.0007
273 HYPERTONIC BLADDER 2 0.0007
274 EYELID MARGIN CRUSTING 2 0.0007
275 COMA SCALE ABNORMAL 2 0.0007
276 ESCHERICHIA SEPSIS 2 0.0007
277 ADENOVIRUS INFECTION 2 0.0007
278 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
279 BILIARY COLIC 2 0.0007
280 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
281 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
282 PHYSICAL DISABILITY 3 0.0007
283 IRON DEFICIENCY 3 0.0007
284 CENTRAL VENOUS CATHETERISATION 2 0.0007
285 LOSS OF EMPLOYMENT 2 0.0007
286 DISEASE COMPLICATION 3 0.0007
287 MEDICAL DEVICE DISCOMFORT 2 0.0007
288 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
289 CHEST X-RAY ABNORMAL 2 0.0007
290 LIVER INJURY 16 0.0007
291 PHARYNGITIS STREPTOCOCCAL 7 0.0006
292 CHRONIC KIDNEY DISEASE 49 0.0006
293 MULTIPLE MYELOMA 3 0.0006
294 UMBILICAL HERNIA 3 0.0006
295 ANXIETY 182 0.0006
296 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
297 SEASONAL ALLERGY 9 0.0006
298 INFUSION SITE PRURITUS 2 0.0006
299 SPUTUM DISCOLOURED 6 0.0006
300 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
301 MALNUTRITION 7 0.0006
302 ENTEROCOCCAL INFECTION 3 0.0006
303 FACET JOINT SYNDROME 2 0.0006
304 LYMPHOCYTE COUNT INCREASED 2 0.0006
305 OSTEOMYELITIS 11 0.0006
306 OSTEONECROSIS OF JAW 15 0.0006
307 ANXIETY DISORDER 2 0.0006
308 DRUG TOLERANCE 3 0.0006
309 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
310 BRONCHIOLITIS 2 0.0006
311 NECROTISING FASCIITIS 2 0.0006
312 BONE EROSION 2 0.0006
313 OBESITY 9 0.0006
314 TOOTH EXTRACTION 7 0.0006
315 CONJUNCTIVAL HYPERAEMIA 2 0.0006
316 FACIAL BONES FRACTURE 2 0.0006
317 MONOCYTE COUNT INCREASED 2 0.0006
318 END STAGE RENAL DISEASE 10 0.0005
319 UTERINE LEIOMYOMA 4 0.0005
320 ORAL DISORDER 4 0.0005
321 HYPERKERATOSIS 3 0.0005
322 URTICARIA 91 0.0005
323 BONE DENSITY DECREASED 17 0.0005
324 ALCOHOL USE 2 0.0005
325 IRON DEFICIENCY ANAEMIA 5 0.0005
326 HYPOPHOSPHATAEMIA 4 0.0005
327 ARTHROPOD BITE 4 0.0005
328 CONJUNCTIVITIS 10 0.0005
329 APPENDICITIS 5 0.0005
330 DEFORMITY 5 0.0005
331 EYE INFECTION 6 0.0005
332 CATHETER SITE INFECTION 2 0.0005
333 CHEMOTHERAPY 2 0.0005
334 PULMONARY HYPERTENSION 11 0.0005
335 EXERCISE TOLERANCE DECREASED 3 0.0005
336 SKIN ATROPHY 3 0.0005
337 GINGIVAL DISORDER 2 0.0005
338 RENAL FAILURE CHRONIC 4 0.0005
339 PRESCRIBED OVERDOSE 10 0.0005
340 BACTERAEMIA 6 0.0005
341 AZOTAEMIA 2 0.0005
342 BLEPHARITIS 2 0.0005
343 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
344 CONDITION AGGRAVATED 150 0.0005
345 IMPAIRED QUALITY OF LIFE 7 0.0005
346 HYPERURICAEMIA 2 0.0005
347 ESCHERICHIA INFECTION 4 0.0005
348 PHARYNGITIS 6 0.0005
349 SLEEP DISORDER 34 0.0005
350 TENDERNESS 5 0.0005
351 SKIN LESION 13 0.0005
352 CANDIDA INFECTION 8 0.0005
353 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
354 HEPATIC CYTOLYSIS 6 0.0005
355 ABSCESS LIMB 2 0.0005
356 BODY HEIGHT DECREASED 5 0.0005
357 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
358 PSEUDOMONAS INFECTION 4 0.0005
359 BONE LOSS 7 0.0005
360 CARDIAC FLUTTER 3 0.0005
361 PSYCHOLOGICAL TRAUMA 4 0.0005
362 PAIN IN JAW 13 0.0005
363 OESOPHAGITIS 5 0.0005
364 HYPOGAMMAGLOBULINAEMIA 3 0.0005
365 MELANOCYTIC NAEVUS 2 0.0005
366 SKIN EXFOLIATION 38 0.0004
367 VENTRICULAR FIBRILLATION 5 0.0004
368 SWELLING 42 0.0004
369 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
370 HAEMOGLOBIN INCREASED 2 0.0004
371 ABDOMINAL HERNIA 2 0.0004
372 DERMATITIS CONTACT 5 0.0004
373 HAIR GROWTH ABNORMAL 3 0.0004
374 PRODUCT DISTRIBUTION ISSUE 4 0.0004
375 GASTRITIS EROSIVE 2 0.0004
376 NEPHROPATHY 4 0.0004
377 PHOTOPHOBIA 8 0.0004
378 PAIN IN EXTREMITY 125 0.0004
379 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
380 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
381 PROTEINURIA 8 0.0004
382 HYPERLIPIDAEMIA 5 0.0004
383 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
384 LIMB OPERATION 2 0.0004
385 CELLULITIS 21 0.0004
386 GASTROINTESTINAL TOXICITY 2 0.0004
387 INJURY 29 0.0004
388 MOUTH HAEMORRHAGE 3 0.0004
389 RENAL TUBULAR NECROSIS 4 0.0004
390 KIDNEY INFECTION 8 0.0004
391 SENSITIVE SKIN 3 0.0004
392 LABORATORY TEST ABNORMAL 12 0.0004
393 CARDIOMEGALY 5 0.0004
394 BREATH SOUNDS ABNORMAL 2 0.0004
395 STEVENS-JOHNSON SYNDROME 9 0.0004
396 ORGANISING PNEUMONIA 2 0.0004
397 HAEMATOCRIT DECREASED 8 0.0004
398 CYST 5 0.0004
399 IMMUNODEFICIENCY 6 0.0004
400 DERMATITIS EXFOLIATIVE 2 0.0004
401 DYSPNOEA 225 0.0004
402 FULL BLOOD COUNT DECREASED 8 0.0004
403 DYSLIPIDAEMIA 2 0.0004
404 BOWEL MOVEMENT IRREGULARITY 3 0.0004
405 FEMORAL NECK FRACTURE 2 0.0004
406 RIB FRACTURE 8 0.0004
407 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
408 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
409 POOR VENOUS ACCESS 4 0.0004
410 HYPOALBUMINAEMIA 3 0.0004
411 WEIGHT FLUCTUATION 4 0.0004
412 PRODUCT ODOUR ABNORMAL 4 0.0004
413 INJECTION SITE DISCOMFORT 4 0.0004
414 BLOOD LACTIC ACID INCREASED 2 0.0004
415 PULMONARY CONGESTION 5 0.0004
416 ACUTE KIDNEY INJURY 58 0.0004
417 NASAL DISCOMFORT 3 0.0004
418 GINGIVAL PAIN 3 0.0004
419 EATING DISORDER 8 0.0004
420 BACTERIAL INFECTION 7 0.0004
421 OVERWEIGHT 2 0.0004
422 NEURALGIA 9 0.0004
423 CHEILITIS 2 0.0004
424 PRODUCT TASTE ABNORMAL 5 0.0004
425 POST PROCEDURAL INFECTION 3 0.0004
426 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
427 BLOOD POTASSIUM DECREASED 11 0.0004
428 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
429 MUSCLE INJURY 3 0.0004
430 DIVERTICULITIS 10 0.0004
431 PLASMA CELL MYELOMA 14 0.0004
432 INFUSION SITE ERYTHEMA 3 0.0004
433 FACE OEDEMA 6 0.0004
434 UTERINE PERFORATION 3 0.0004
435 RENAL FAILURE 47 0.0004
436 OSTEOARTHRITIS 15 0.0004
437 CHOLECYSTITIS ACUTE 2 0.0004
438 SWOLLEN TONGUE 11 0.0004
439 UNRESPONSIVE TO STIMULI 9 0.0003
440 CORONARY ARTERY BYPASS 2 0.0003
441 BLOOD MAGNESIUM DECREASED 3 0.0003
442 EMOTIONAL DISTRESS 42 0.0003
443 PYELONEPHRITIS 3 0.0003
444 RESPIRATORY TRACT INFECTION 9 0.0003
445 HYPERVENTILATION 2 0.0003
446 EOSINOPHILIA 6 0.0003
447 HYPOVOLAEMIA 2 0.0003
448 DRUG INTOLERANCE 33 0.0003
449 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
450 LYMPHOCYTE COUNT DECREASED 6 0.0003
451 PURPURA 3 0.0003
452 LYMPHADENOPATHY 12 0.0003
453 DEEP VEIN THROMBOSIS 22 0.0003
454 CARDIOMYOPATHY 5 0.0003
455 RESPIRATORY RATE INCREASED 3 0.0003
456 ATAXIA 4 0.0003
457 NEUROPATHY PERIPHERAL 32 0.0003
458 GASTROINTESTINAL INFECTION 3 0.0003
459 LEUKOCYTOSIS 6 0.0003
460 BURSITIS 4 0.0003
461 DYSURIA 12 0.0003
462 ENCEPHALOPATHY 8 0.0003
463 DEVICE RELATED INFECTION 5 0.0003
464 MUSCULOSKELETAL CHEST PAIN 5 0.0003
465 WOUND 9 0.0003
466 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
467 DERMATITIS ALLERGIC 4 0.0003
468 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
469 SPINAL DISORDER 3 0.0003
470 SEPSIS 35 0.0003
471 FOREIGN BODY SENSATION IN EYES 2 0.0003
472 HYPERKALAEMIA 11 0.0003
473 HEART RATE DECREASED 11 0.0003
474 RASH 136 0.0003
475 DIZZINESS POSTURAL 3 0.0003
476 PHARYNGEAL SWELLING 3 0.0003
477 ARTHROPATHY 17 0.0003
478 METASTASES TO BONE 5 0.0003
479 MULTIPLE FRACTURES 5 0.0003
480 HOSPICE CARE 3 0.0003
481 STAPHYLOCOCCAL INFECTION 10 0.0003
482 BLOOD PRESSURE ABNORMAL 6 0.0003
483 APPETITE DISORDER 2 0.0003
484 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
485 FUNGAL INFECTION 10 0.0003
486 PNEUMONIA 97 0.0003
487 MENINGITIS 2 0.0003
488 CHOLECYSTITIS CHRONIC 2 0.0003
489 SEPTIC SHOCK 13 0.0003
490 BREAST MASS 2 0.0003
491 PERICARDITIS 5 0.0003
492 PLEURAL EFFUSION 18 0.0003
493 GINGIVAL BLEEDING 4 0.0003
494 EAR DISCOMFORT 3 0.0003
495 HAEMOGLOBIN DECREASED 30 0.0003
496 SWELLING FACE 19 0.0003
497 PLATELET COUNT DECREASED 31 0.0003
498 INFLAMMATION 15 0.0003
499 LARGE INTESTINE POLYP 2 0.0003
500 MENTAL STATUS CHANGES 8 0.0003
501 HYPERTRANSAMINASAEMIA 2 0.0003
502 APHONIA 4 0.0003
503 DERMATITIS 6 0.0003
504 SYRINGE ISSUE 5 0.0003
505 FOETAL EXPOSURE DURING PREGNANCY 23 0.0003
506 HAND FRACTURE 2 0.0003
507 GALLBLADDER DISORDER 5 0.0003
508 LIVER FUNCTION TEST INCREASED 6 0.0003
509 INFLUENZA LIKE ILLNESS 23 0.0003
510 CARDIOGENIC SHOCK 4 0.0003
511 GOUT 5 0.0003
512 MYELODYSPLASTIC SYNDROME 4 0.0003
513 BLOOD CREATININE INCREASED 18 0.0003
514 C-REACTIVE PROTEIN INCREASED 10 0.0003
515 GASTROENTERITIS 4 0.0003
516 MAJOR DEPRESSION 2 0.0003
517 SINUSITIS 28 0.0003
518 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
519 SKIN ULCER 7 0.0003
520 RASH GENERALISED 7 0.0003
521 LIP SWELLING 9 0.0003
522 URINARY TRACT INFECTION 46 0.0003
523 DIPLOPIA 7 0.0003
524 PULMONARY MASS 4 0.0003
525 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
526 THROMBOCYTOPENIA 30 0.0003
527 SKIN INFECTION 3 0.0003
528 OCULAR DISCOMFORT 3 0.0003
529 HYDRONEPHROSIS 2 0.0003
530 MITRAL VALVE INCOMPETENCE 3 0.0003
531 FRACTURE 5 0.0003
532 FOOT FRACTURE 5 0.0003
533 MICTURITION URGENCY 3 0.0003
534 ILLNESS 27 0.0003
535 ACIDOSIS 2 0.0003
536 INSURANCE ISSUE 4 0.0003
537 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
538 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
539 PERICARDIAL EFFUSION 6 0.0003
540 RASH PRURITIC 14 0.0003
541 EAR PAIN 5 0.0003
542 APNOEA 2 0.0003
543 BRONCHITIS 19 0.0003
544 BRAIN FOG 4 0.0003
545 DEHYDRATION 34 0.0003
546 COVID-19 PNEUMONIA 3 0.0003
547 PRODUCT PRESCRIBING ERROR 6 0.0003
548 CHOLECYSTITIS 3 0.0003
549 LOW BIRTH WEIGHT BABY 2 0.0003
550 ULCER 4 0.0003
551 RASH ERYTHEMATOUS 12 0.0003
552 UPPER LIMB FRACTURE 5 0.0003
553 ABSCESS 4 0.0003
554 OROPHARYNGEAL PAIN 23 0.0002
555 EYE PAIN 14 0.0002
556 LOCALISED INFECTION 6 0.0002
557 SUICIDE ATTEMPT 15 0.0002
558 ADRENAL INSUFFICIENCY 3 0.0002
559 HYPERGLYCAEMIA 9 0.0002
560 MUSCLE DISORDER 2 0.0002
561 BACK DISORDER 4 0.0002
562 DISCOMFORT 15 0.0002
563 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
564 ANGINA PECTORIS 7 0.0002
565 OSTEOPOROSIS 10 0.0002
566 EYE SWELLING 9 0.0002
567 DRUG LEVEL INCREASED 4 0.0002
568 CYTOMEGALOVIRUS INFECTION 4 0.0002
569 NEEDLE ISSUE 7 0.0002
570 EOSINOPHIL COUNT INCREASED 2 0.0002
571 LIVE BIRTH 2 0.0002
572 BONE PAIN 14 0.0002
573 DYSPNOEA EXERTIONAL 9 0.0002
574 BLOOD UREA INCREASED 4 0.0002
575 ASCITES 7 0.0002
576 MOUTH ULCERATION 5 0.0002
577 RENAL INJURY 7 0.0002
578 HAEMATOCHEZIA 13 0.0002
579 COVID-19 41 0.0002
580 SCAR 4 0.0002
581 ROTATOR CUFF SYNDROME 3 0.0002
582 GENITAL HAEMORRHAGE 3 0.0002
583 INFUSION SITE PAIN 3 0.0002
584 PANCYTOPENIA 13 0.0002
585 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
586 ANURIA 2 0.0002
587 PYREXIA 80 0.0002
588 MUSCLE STRAIN 2 0.0002
589 DELIRIUM 8 0.0002
590 LOCAL SWELLING 4 0.0002
591 MUCOSAL INFLAMMATION 6 0.0002
592 SARS-COV-2 TEST POSITIVE 3 0.0002
593 BRADYCARDIA 12 0.0002
594 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
595 HYPOTENSION 45 0.0002
596 INFLUENZA 25 0.0002
597 JOINT RANGE OF MOTION DECREASED 3 0.0002
598 ORAL PAIN 5 0.0002
599 HAEMOLYTIC ANAEMIA 2 0.0002
600 NASOPHARYNGITIS 41 0.0002
601 ANAL INCONTINENCE 2 0.0002
602 HEAVY MENSTRUAL BLEEDING 2 0.0002
603 BLOOD BILIRUBIN INCREASED 6 0.0002
604 DEVELOPMENTAL DELAY 2 0.0002
605 GASTROENTERITIS VIRAL 4 0.0002
606 NASAL CONGESTION 13 0.0002
607 DRY EYE 11 0.0002
608 CYSTITIS 7 0.0002
609 PRODUCT AVAILABILITY ISSUE 5 0.0002
610 CORONARY ARTERY OCCLUSION 3 0.0002
611 TINNITUS 10 0.0002
612 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
613 RENAL IMPAIRMENT 18 0.0002
614 LACERATION 2 0.0002
615 HYPERTENSION 45 0.0002
616 RENAL FAILURE ACUTE 9 0.0002
617 GASTROINTESTINAL DISORDER 19 0.0002
618 FLATULENCE 12 0.0002
619 INTENTIONAL DOSE OMISSION 6 0.0002
620 VIRAL INFECTION 7 0.0002
621 SLEEP APNOEA SYNDROME 4 0.0002
622 HERPES ZOSTER 12 0.0002
623 DEPRESSED MOOD 11 0.0002
624 PARAESTHESIA ORAL 3 0.0002
625 ACUTE RESPIRATORY FAILURE 4 0.0002
626 INFECTION 30 0.0002
627 HYPERCHOLESTEROLAEMIA 2 0.0002
628 COUGH 58 0.0002
629 ABDOMINAL PAIN 48 0.0002
630 RESPIRATORY FAILURE 15 0.0002
631 PRURITUS 79 0.0002
632 ANAEMIA 39 0.0002
633 COELIAC DISEASE 2 0.0002
634 BODY TEMPERATURE DECREASED 2 0.0002
635 OEDEMA 11 0.0002
636 MUSCULAR WEAKNESS 23 0.0002
637 LIGAMENT SPRAIN 2 0.0002
638 BLADDER DISORDER 2 0.0002
639 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
640 ABDOMINAL DISTENSION 21 0.0002
641 RHINORRHOEA 13 0.0002
642 PRODUCT DOSE OMISSION ISSUE 59 0.0002
643 RESPIRATORY DISORDER 6 0.0002
644 OVARIAN CYST 2 0.0002
645 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
646 BRAIN INJURY 2 0.0002
647 EMPHYSEMA 2 0.0002
648 PRODUCT ADMINISTRATION ERROR 4 0.0002
649 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
650 HYPOTHERMIA 2 0.0002
651 ILL-DEFINED DISORDER 12 0.0002
652 HAEMATEMESIS 5 0.0002
653 CONSTIPATION 43 0.0002
654 MOTOR DYSFUNCTION 2 0.0002
655 OXYGEN SATURATION DECREASED 11 0.0002
656 CEREBRAL HAEMORRHAGE 7 0.0002
657 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
658 ATRIAL FIBRILLATION 19 0.0002
659 DRUG RESISTANCE 5 0.0002
660 LIMB DISCOMFORT 6 0.0002
661 RENAL DISORDER 9 0.0002
662 EJECTION FRACTION DECREASED 3 0.0002
663 EYE DISCHARGE 2 0.0002
664 FATIGUE 149 0.0002
665 DERMATITIS ATOPIC 10 0.0002
666 PERIPHERAL SWELLING 29 0.0002
667 EAR INFECTION 5 0.0002
668 SURGERY 11 0.0002
669 EPISTAXIS 14 0.0002
670 JAUNDICE 5 0.0002
671 DECREASED ACTIVITY 2 0.0002
672 FAECES DISCOLOURED 4 0.0002
673 BIPOLAR DISORDER 2 0.0002
674 CHOLELITHIASIS 6 0.0002
675 OSTEONECROSIS 6 0.0002
676 ASPIRATION 2 0.0002
677 THERAPY INTERRUPTED 13 0.0002
678 VENTRICULAR TACHYCARDIA 3 0.0002
679 PHOTOSENSITIVITY REACTION 3 0.0002
680 STOMATITIS 11 0.0002
681 NERVE INJURY 2 0.0002
682 MUSCLE SPASMS 33 0.0002
683 RASH MACULO-PAPULAR 4 0.0002
684 NEOPLASM MALIGNANT 12 0.0002
685 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
686 NECK PAIN 10 0.0002
687 ADVERSE DRUG REACTION 16 0.0002
688 ARTHRITIS 14 0.0002
689 FISTULA 2 0.0002
690 CONTUSION 17 0.0002
691 MYALGIA 30 0.0002
692 CHEST DISCOMFORT 18 0.0002
693 INTERNAL HAEMORRHAGE 2 0.0002
694 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
695 PAIN 107 0.0002
696 GAIT DISTURBANCE 33 0.0002
697 BLOOD CHOLESTEROL INCREASED 8 0.0002
698 MUSCULOSKELETAL STIFFNESS 15 0.0002
699 AMENORRHOEA 3 0.0002
700 SYNCOPE 17 0.0002
701 DYSPHAGIA 16 0.0002
702 BACK PAIN 39 0.0002
703 PREMATURE BABY 5 0.0002
704 HEPATITIS C 2 0.0002
705 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
706 MENTAL IMPAIRMENT 4 0.0002
707 PANIC ATTACK 6 0.0002
708 OEDEMA PERIPHERAL 20 0.0002
709 RECTAL HAEMORRHAGE 7 0.0002
710 INJECTION SITE MASS 6 0.0002
711 HYPERCALCAEMIA 2 0.0002
712 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
713 BLOOD SODIUM DECREASED 3 0.0002
714 DEPRESSION 36 0.0002
715 ABDOMINAL PAIN LOWER 4 0.0002
716 MUSCLE ATROPHY 2 0.0002
717 TACHYCARDIA 14 0.0002
718 DIABETES MELLITUS 12 0.0002
719 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
720 INTENTIONAL OVERDOSE 10 0.0002
721 MOVEMENT DISORDER 5 0.0002
722 ABDOMINAL PAIN UPPER 32 0.0002
723 HIATUS HERNIA 2 0.0002
724 INJECTION SITE INDURATION 2 0.0002
725 OFF LABEL USE 135 0.0002
726 ARTHRALGIA 64 0.0002
727 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
728 CHILLS 18 0.0002
729 SKIN FISSURES 3 0.0002
730 VOMITING 72 0.0002
731 IMPAIRED HEALING 5 0.0002
732 INCORRECT PRODUCT STORAGE 2 0.0002
733 EYE DISORDER 5 0.0002
734 GASTRITIS 4 0.0002
735 ORAL CANDIDIASIS 2 0.0002
736 DIARRHOEA 98 0.0002
737 ANKYLOSING SPONDYLITIS 2 0.0002
738 DISABILITY 3 0.0002
739 SINUS DISORDER 3 0.0002
740 DISORIENTATION 6 0.0002
741 INFUSION RELATED REACTION 10 0.0002
742 FEBRILE NEUTROPENIA 10 0.0002
743 BLOOD PRESSURE DECREASED 10 0.0002
744 WEIGHT DECREASED 42 0.0002
745 PRESCRIBED UNDERDOSE 3 0.0002
746 ABORTION SPONTANEOUS 6 0.0001
747 SPINAL FRACTURE 3 0.0001
748 FEAR 4 0.0001
749 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
750 FEEDING DISORDER 3 0.0001
751 DRY MOUTH 12 0.0001
752 ARRHYTHMIA 7 0.0001
753 LIMB INJURY 4 0.0001
754 CHEST PAIN 27 0.0001
755 VISION BLURRED 20 0.0001
756 HYPOGLYCAEMIA 7 0.0001
757 ORAL DISCOMFORT 2 0.0001
758 HYPOMAGNESAEMIA 2 0.0001
759 INJECTION SITE SWELLING 11 0.0001
760 HEADACHE 90 0.0001
761 COORDINATION ABNORMAL 2 0.0001
762 MYOCARDIAL INFARCTION 25 0.0001
763 MASS 2 0.0001
764 BURNING SENSATION 10 0.0001
765 BLISTER 8 0.0001
766 HALLUCINATION, VISUAL 3 0.0001
767 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
768 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
769 ADVERSE EVENT 13 0.0001
770 ASTHENIA 53 0.0001
771 DIALYSIS 2 0.0001
772 RETCHING 3 0.0001
773 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
774 BRONCHOSPASM 2 0.0001
775 RED BLOOD CELL COUNT DECREASED 4 0.0001
776 NEUTROPENIA 19 0.0001
777 SKIN CANCER 3 0.0001
778 DEVICE DISLOCATION 6 0.0001
779 PRODUCT PRESCRIBING ISSUE 3 0.0001
780 FLUID OVERLOAD 2 0.0001
781 BLOOD PRESSURE INCREASED 21 0.0001
782 CARDIAC FAILURE CONGESTIVE 11 0.0001
783 RESTLESSNESS 5 0.0001
784 MIGRAINE 13 0.0001
785 ANGIOEDEMA 6 0.0001
786 CATARACT 8 0.0001
787 COLITIS ULCERATIVE 6 0.0001
788 HAEMORRHAGE INTRACRANIAL 2 0.0001
789 SNEEZING 3 0.0001
790 CHROMATURIA 3 0.0001
791 BLOOD COUNT ABNORMAL 2 0.0001
792 COLITIS 5 0.0001
793 NAUSEA 104 0.0001
794 HEART RATE INCREASED 13 0.0001
795 SUICIDAL IDEATION 12 0.0001
796 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
797 HOSPITALISATION 20 0.0001
798 HYPOKALAEMIA 6 0.0001
799 DISTURBANCE IN ATTENTION 7 0.0001
800 ANKLE FRACTURE 2 0.0001
801 ACUTE MYELOID LEUKAEMIA 2 0.0001
802 CARDIAC DISORDER 12 0.0001
803 BASAL CELL CARCINOMA 2 0.0001
804 ALOPECIA 25 0.0001
805 PARAESTHESIA 20 0.0001
806 HEAD INJURY 4 0.0001
807 MEDICATION ERROR 7 0.0001
808 HALLUCINATION, AUDITORY 2 0.0001
809 DIABETIC KETOACIDOSIS 3 0.0001
810 LOSS OF CONSCIOUSNESS 16 0.0001
811 JOINT SWELLING 15 0.0001
812 NIGHT SWEATS 4 0.0001
813 MUSCLE TIGHTNESS 2 0.0001
814 PRESYNCOPE 3 0.0001
815 AMNESIA 8 0.0001
816 LETHARGY 7 0.0001
817 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
818 AGEUSIA 3 0.0001
819 SKIN DISORDER 4 0.0001
820 RHABDOMYOLYSIS 5 0.0001
821 UNEVALUABLE EVENT 9 0.0001
822 TYPE 2 DIABETES MELLITUS 4 0.0001
823 TOXICITY TO VARIOUS AGENTS 20 0.0001
824 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
825 CIRCULATORY COLLAPSE 2 0.0001
826 HYPOPHAGIA 3 0.0001
827 ANAPHYLACTIC SHOCK 3 0.0001
828 MUSCULOSKELETAL DISCOMFORT 2 0.0001
829 PARANOIA 2 0.0001
830 HAEMATOMA 3 0.0001
831 MULTI-ORGAN FAILURE 2 0.0001
832 ORTHOSTATIC HYPOTENSION 2 0.0001
833 SEDATION 3 0.0001
834 TREMOR 19 0.0001
835 NEUROTOXICITY 2 0.0001
836 DEATH 98 0.0001
837 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
838 HEAD DISCOMFORT 2 0.0001
839 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
840 DRUG ERUPTION 2 0.0001
841 INSOMNIA 30 0.0001
842 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
843 DECREASED APPETITE 26 0.0001
844 DYSPEPSIA 11 0.0001
845 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
846 THROAT IRRITATION 5 0.0001
847 MOBILITY DECREASED 8 0.0001
848 THERAPY NON-RESPONDER 5 0.0001
849 CRYING 4 0.0001
850 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
851 CARDIAC ARREST 9 0.0001
852 AGRANULOCYTOSIS 2 0.0001
853 HEPATIC STEATOSIS 2 0.0001
854 ABDOMINAL DISCOMFORT 18 0.0001
855 COGNITIVE DISORDER 5 0.0001
856 HYPONATRAEMIA 6 0.0001
857 HOT FLUSH 8 0.0001
858 HYPOCALCAEMIA 2 0.0001
859 OCULAR HYPERAEMIA 5 0.0001
860 BLOOD URINE PRESENT 2 0.0001
861 MUSCULOSKELETAL DISORDER 2 0.0001
862 MALAISE 46 0.0001
863 DRY SKIN 14 0.0001
864 HYPERSOMNIA 3 0.0001
865 DIZZINESS 52 0.0001
866 HERNIA 2 0.0001
867 ERUCTATION 2 0.0001
868 LIVER FUNCTION TEST ABNORMAL 3 0.0001
869 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
870 HAEMORRHOIDS 2 0.0001
871 ORAL HERPES 2 0.0001
872 FALL 34 0.0001
873 DISEASE PROGRESSION 12 0.0001
874 BLOOD GLUCOSE INCREASED 19 0.0001
875 LEUKOPENIA 5 0.0001
876 CARDIAC FAILURE 8 0.0001
877 SOMNOLENCE 20 0.0001
878 LACRIMATION INCREASED 3 0.0001
879 FLUID RETENTION 5 0.0001
880 WEIGHT INCREASED 22 0.0001
881 FEELING HOT 6 0.0001
882 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
883 TREATMENT FAILURE 8 0.0001
884 POLLAKIURIA 4 0.0001
885 NERVOUSNESS 5 0.0001
886 CARDIO-RESPIRATORY ARREST 4 0.0001
887 DRUG-INDUCED LIVER INJURY 3 0.0001
888 ECZEMA 5 0.0001
889 MEMORY IMPAIRMENT 13 0.0001
890 PALPITATIONS 11 0.0001
891 METABOLIC ACIDOSIS 3 0.0001
892 JOINT INJURY 2 0.0001
893 DRUG DEPENDENCE 15 0.0001
894 HYPERHIDROSIS 12 0.0001
895 HYPOACUSIS 4 0.0001
896 HALLUCINATION 7 0.0001
897 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
898 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
899 MENTAL DISORDER 4 0.0001
900 MELAENA 2 0.0001
901 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
902 URINARY RETENTION 3 0.0001
903 HEPATOTOXICITY 2 0.0001
904 FLUSHING 9 0.0001
905 HEART RATE IRREGULAR 2 0.0001
906 RHEUMATOID ARTHRITIS 10 0.0001
907 HEPATIC ENZYME INCREASED 6 0.0001
908 HAEMATURIA 3 0.0001
909 NEPHROLITHIASIS 4 0.0001
910 SKIN DISCOLOURATION 4 0.0001
911 SEIZURE 10 0.0001
912 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
913 DYSPHONIA 5 0.0001
914 PSORIASIS 11 0.0001
915 BLOOD PRESSURE FLUCTUATION 2 0.0001
916 BLOOD GLUCOSE DECREASED 4 0.0001
917 INTERSTITIAL LUNG DISEASE 4 0.0001
918 ACCIDENTAL OVERDOSE 3 0.0001
919 DRUG INEFFECTIVE 108 0.0001
920 INJECTION SITE URTICARIA 2 0.0001
921 CONFUSIONAL STATE 13 0.0001
922 HYPOAESTHESIA 12 0.0001
923 DRUG WITHDRAWAL SYNDROME 7 0.0001
924 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
925 PRODUCT DOSE OMISSION 5 0.0001
926 DEAFNESS 2 0.0001
927 MUSCULOSKELETAL PAIN 4 0.0001
928 SPEECH DISORDER 4 0.0001
929 PANCREATITIS 4 0.0001
930 MENSTRUATION IRREGULAR 2 0.0001
931 DYSKINESIA 3 0.0001
932 BLINDNESS 3 0.0001
933 NEUTROPHIL COUNT DECREASED 3 0.0001
934 ROAD TRAFFIC ACCIDENT 3 0.0001
935 DEMENTIA 2 0.0001
936 DRUG INTERACTION 11 0.0001
937 INTENTIONAL PRODUCT MISUSE 6 0.0001
938 DYSSTASIA 2 0.0001
939 ERYTHEMA 14 0.0001
940 AGITATION 5 0.0001
941 ACUTE MYOCARDIAL INFARCTION 2 0.0001
942 LIVER DISORDER 3 0.0001
943 PULMONARY OEDEMA 3 0.0001
944 IRRITABILITY 4 0.0001
945 CORONARY ARTERY DISEASE 2 0.0001
946 FEMUR FRACTURE 2 0.0001
947 DISEASE RECURRENCE 3 0.0001
948 MOOD SWINGS 2 0.0001
949 HIP FRACTURE 2 0.0001
950 INJECTION SITE PAIN 19 0.0001
951 LACTIC ACIDOSIS 2 0.0001
952 EXPIRED PRODUCT ADMINISTERED 2 0.0001
953 DRUG ABUSE 5 0.0001
954 AGGRESSION 3 0.0001
955 GAIT INABILITY 2 0.0001
956 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
957 ANGER 2 0.0001
958 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
959 FEELING ABNORMAL 14 0.0001
960 BALANCE DISORDER 5 0.0001
961 DEVICE ISSUE 5 0.0001
962 MYELOSUPPRESSION 2 0.0001
963 TREATMENT NONCOMPLIANCE 3 0.0001
964 DYSGEUSIA 4 0.0001
965 HEPATIC FUNCTION ABNORMAL 2 0.0001
966 PRODUCT USE ISSUE 10 0.0001
967 DYSARTHRIA 2 0.0001
968 INTESTINAL OBSTRUCTION 2 0.0001
969 INCORRECT DOSE ADMINISTERED 12 0.0001
970 EYE IRRITATION 3 0.0001
971 ABNORMAL BEHAVIOUR 2 0.0001
972 THERAPEUTIC RESPONSE DECREASED 3 0.0000
973 VISUAL IMPAIRMENT 6 0.0000
974 INJECTION SITE ERYTHEMA 6 0.0000
975 HAEMORRHAGE 5 0.0000
976 PRODUCT STORAGE ERROR 4 0.0000
977 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
978 INJECTION SITE PRURITUS 3 0.0000
979 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
980 OVERDOSE 9 0.0000
981 CEREBROVASCULAR ACCIDENT 7 0.0000
982 ACNE 3 0.0000
983 CONVULSION 2 0.0000
984 NO ADVERSE EVENT 6 0.0000
985 EXPOSURE DURING PREGNANCY 2 0.0000
986 DEVICE MALFUNCTION 2 0.0000
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
988 INJECTION SITE BRUISING 2 0.0000
989 INJECTION SITE HAEMORRHAGE 2 0.0000
990 DRUG DOSE OMISSION 3 0.0000